Telomir Pharmaceuticals, Inc. Common Stock (TELO)
Healthcare
Biotechnology
1.20 $
-3.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Telomir Pharmaceuticals, Inc. Common Stock (TELO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 69.1% of the shares are freely tradable; institutional investors hold 3.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
3.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
35.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
69.1%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
1.7%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
69Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Group Inc | 1.65 | 1,137,466 | +3.2 | 12/31/2025 |
| Vanguard Capital Management, LLC | 1.45 | 995,373 | +0.0 | 03/31/2026 |
| BlackRock Inc | 0.42 | 289,198 | +1.3 | 03/31/2026 |
| Geode Capital Management, LLC | 0.36 | 249,086 | +11.4 | 03/31/2026 |
| Vanguard Fiduciary Trust Co | 0.20 | 135,541 | +0.0 | 03/31/2026 |
| Millennium Management LLC | 0.19 | 129,060 | -22.7 | 03/31/2026 |
| State Street Corp | 0.09 | 58,600 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.19 | 815,408 | +0.0 | 04/30/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.31 | 214,940 | +19.4 | 04/30/2026 |
| Fidelity Extended Market Index | 0.18 | 125,078 | -0.4 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.